Golden Helix is proud to be recognized as a top biotechnology solution provider, named one of MirrorReview’s 10 Innovative Biotechnology Solution Companies for 2021. This acknowledgment reflects over two decades of dedication to advancing bioinformatics and empowering the global genomics community. Our success would not be possible without the support of our incredible customers, partners, and team members.

If you’re interested in learning more about our journey and what sets Golden Helix apart, you can read the full article here: MirrorReview Feature.

“Biotechnology has had a major role in evolving the health and medicine industry. In the past 50 years, the industry has led to the discovery of some of the remarkable solutions in history. Recently, The Human Genome Project, which took 13 years and wrapped up ahead of schedule in 2003, is now considered the stepping stone of modern genetic testing. With the rise in the demand for clinical research, solutions like bioinformatics are being sought highly.

In this ever-changing age of innovative biotechnology, Golden Helix has been delivering leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years. It provides innovative technological and analytic services that empower scientists and healthcare professionals in deriving meaning from the rapidly increasing volumes of genomic data.”

As the demand for high-impact biotechnology solutions continues to grow, Golden Helix remains committed to innovation, precision, and service. We’re honored to stand alongside other leaders shaping the future of genomics and personalized medicine—and we look forward to what’s next.